A 2021 study in Molecular Cell identified that under oxidative stress, the protein SUCLA2 activates the enzyme GLS, enhancing metabolic activity to support pancreatic cancer survival. This SUCLA2-GLS pathway promotes tumor growth by increasing glutaminolysis, offering a potential target for therapeutic intervention. Read the full study at ScienceDirect.